Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms
Robert T. Jensen, Lisa Bodei, Jaume Capdevila, et al.
Neuroendocrinology (2018) Vol. 108, Iss. 1, pp. 26-36
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience
Kira Oleinikov, Inbal Uri, Harold Jacob, et al.
Endocrine (2020) Vol. 68, Iss. 1, pp. 222-229
Closed Access | Times Cited: 11
Portal vein resection in pancreatic neuroendocrine neoplasms
Anna Nießen, Ulla Klaiber, Magdalena Lewosinska, et al.
Surgery (2024) Vol. 175, Iss. 4, pp. 1154-1161
Closed Access | Times Cited: 1
Non-Functioning Pancreatic Neuroendocrine Tumors
Nicola Fazio, Anna Koumarianou
Springer eBooks (2024), pp. 315-347
Closed Access | Times Cited: 1
Quality of Pancreatic Neuroendocrine Tumor Videos Available on TikTok and Bilibili: Content Analysis
Zheyu Niu, Yijie Hao, Faji Yang, et al.
JMIR Formative Research (2024) Vol. 8, pp. e60033-e60033
Open Access | Times Cited: 1
Unmet Needs in the Field of Neuroendocrine Neoplasms of the Gastrointestinal Tract, Pancreas, and Respiratory System: Reports by the ENETS Group
Wouter W. de Herder, Jaume Capdevila
Neuroendocrinology (2018) Vol. 108, Iss. 1, pp. 5-6
Open Access | Times Cited: 10
A semicentennial of pancreatic pathology: the genetic revolution is here, but don’t throw the baby out with the bath water!
Ralph H. Hruban, David S. Klimstra, Giuseppe Zamboni, et al.
Human Pathology (2019) Vol. 95, pp. 99-112
Closed Access | Times Cited: 10
Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study
Burcin Özdirik, Anna Kathrin Stueven, Raphael Mohr, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2881-2881
Open Access | Times Cited: 10
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors
Véronique Debien, Guillaume Davidson, Philippe Baltzinger, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2771-2771
Open Access | Times Cited: 8
Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review
Jeffrey Chen, Charlotte M. Heidsma, Anton F. Engelsman, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1525-1525
Open Access | Times Cited: 3
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms
Giuseppe Fanciulli, Anna La Salvia, Sergio Di Molfetta, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7557-7557
Open Access | Times Cited: 3
Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors
Shengwei Mo, Liju Zong, Xianlong Chen, et al.
Archives of Pathology & Laboratory Medicine (2022) Vol. 147, Iss. 2, pp. 193-201
Open Access | Times Cited: 5
Surgical Indications and Outcomes of Resection for Pancreatic Neuroendocrine Tumors with Vascular Involvement
Amy Y. Li, Brendan C. Visser, Monica M. Dua
Cancers (2022) Vol. 14, Iss. 9, pp. 2312-2312
Open Access | Times Cited: 4
Impact of Pancreatic Neuroendocrine Tumor on Mortality in Patients With von Hippel-Lindau Disease
Liat Arnon, Reut Halperin, Amit Tirosh
Endocrine Practice (2021) Vol. 27, Iss. 10, pp. 1040-1045
Closed Access | Times Cited: 4
Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese Cohort
Xinchao Ban, Shengwei Mo, Zhaohui Lu, et al.
Neuroendocrinology (2021) Vol. 112, Iss. 5, pp. 510-522
Closed Access | Times Cited: 4
Refractory postoperative Staphylococcus hominis bacteremia in a patient with an ACTH-producing pancreatic neuroendocrine neoplasm: a case report
Ryuta Muraki, Yoshifumi Morita, Kyota Tatsuta, et al.
Surgical Case Reports (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus
A. Viúdez, Guillermo Crespo, María Luisa Gómez Dorronsoro, et al.
Pancreatology (2020) Vol. 21, Iss. 1, pp. 215-223
Closed Access | Times Cited: 3
SQSTM1/p62 is a prognostic molecular marker and potential therapeutic target for pancreatic neuroendocrine tumours
Yu-Li Song, Junhua Weng, Dachun Zhao, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 407-416
Open Access
Diagnostic Anatomic Imaging for Neuroendocrine Neoplasms: Maximizing Strengths and Mitigating Weaknesses
Mina Hesami, Michael A. Blake, Mark Anderson, et al.
Journal of Computer Assisted Tomography (2024) Vol. 48, Iss. 4, pp. 521-532
Closed Access
Overview of Functioning Pancreatic Neuroendocrine Tumors (F-panNETs)
Nicola Fazio, Anna Koumarianou
Springer eBooks (2024), pp. 185-190
Closed Access
Pancreatic neuroendocrine neoplasms
Wouter W. de Herder, Johannes Hofland
Elsevier eBooks (2024)
Closed Access
Peptide receptor radionuclide therapy for GEP-NET: consolidated knowledge and innovative applications
Silvi Telo, Angelina Filice, Annibale Versari, et al.
Clinical and Translational Imaging (2021) Vol. 9, Iss. 5, pp. 423-438
Closed Access | Times Cited: 3
Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors
Hebin Wang, Ding Ding, Tingting Qin, et al.
HPB (2021) Vol. 24, Iss. 5, pp. 681-690
Open Access | Times Cited: 3
Enhanced computed tomography features predict pancreatic neuroendocrine neoplasm with Ki-67 index less than 5%
Haopeng Yu, Mou Li, Dan Cao, et al.
European Journal of Radiology (2021) Vol. 147, pp. 110100-110100
Closed Access | Times Cited: 3
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review
Brigida Anna Maiorano, Giovanni Schinzari, Sabrina Chiloiro, et al.
Protein and Peptide Letters (2020) Vol. 27, Iss. 12, pp. 1276-1287
Closed Access | Times Cited: 2
Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms
Qing-Yang Que, Lin-Cheng Zhang, Jiaqi Bao, et al.
World Journal of Gastrointestinal Surgery (2022) Vol. 14, Iss. 5, pp. 397-408
Open Access | Times Cited: 1

Scroll to top